Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation-Reference-Cited by-同舟云学术

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation

Published:2018-04-17 Issue:29 Volume:9 Page:20476-20489
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Fostier Karel¹,Caers Jo²,Meuleman Nathalie³,Broos Katrijn⁴,Corthals Jurgen⁴,Thielemans Kris⁴,Schots Rik¹,De Keersmaecker Brenda⁴

Affiliation:

1. Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Hematology, Brussels, Belgium

2. Centre Hospitalier Universitaire (CHU) de Liège, Department of Hematology, Liège, Belgium

3. Institut Jules Bordet, Department of Hematology, Brussels, Belgium

4. Vrije Universiteit Brussel (VUB), Laboratory of Molecular and Cellular Therapy, Brussels, Belgium

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of granulocyte colony-stimulating factor effect on the expression of inhibitory receptors by T cells in multiple myeloma;Medical Immunology (Russia);2024-07-27

2. Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs;British Journal of Haematology;2023-09-30

3. Iatrogenic Kaposi’s sarcoma from induction therapy for myeloma: to transplant or not to transplant?;BMJ Case Reports;2023-06

4. The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms;Cancer Immunology, Immunotherapy;2023-04-17

5. Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis;OncoImmunology;2022-11-01